$252.86
-0.20-0.08%
最終更新: Oct 23, 6:10 PM
Benzinga
Benzinga
Benzinga
土曜日, 10 24
Benzinga
© 2026 Benzinga | All Rights Reserved
ResMed (RMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.88 | $2.80 | $2.71 | $2.50 |
| Actual | $2.95 | $2.86 | $2.81 | $2.55 |
| Surprise | +2.43% | +2.14% | +3.69% | +2.00% |
| Revenue | ||||
| Estimate | $1.46B | $1.42B | $1.39B | $1.33B |
| Actual | $1.46B | $1.43B | $1.42B | $1.34B |
| Surprise | +0.09% | +0.67% | +2.00% | +0.62% |
| Metric | Q1 '27E | Q2 '27E | Q3 '27E | Q4 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.67 | $3.02 | $3.15 | $3.26 |
| Revenue | ||||
| Consensus | $1.39B | $1.45B | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q4 | Aug 6, 2026 | $2.95 | $2.88 | 2.43 % |
| Q3 | Apr 30, 2026 | $2.86 | $2.80 | 2.14 % |
| Q2 | Jan 29, 2026 | $2.81 | $2.71 | 3.69 % |
| Q1 | Oct 30, 2025 | $2.55 | $2.50 | 2.00 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q4 | Aug 6, 2026 | $1.46B | $1.46B | 0.09 % |
| Q3 | Apr 30, 2026 | $1.43B | $1.42B | 0.67 % |
| Q2 | Jan 29, 2026 | $1.42B | $1.39B | 2.00 % |
| Q1 | Oct 30, 2025 | $1.34B | $1.33B | 0.62 % |